(N = 837) | Score | 95% CI | p-value | N |
---|---|---|---|---|
PHQ-9 | ||||
Pre-treatment | 10.37 | [9.96, 10.78] | – | – |
Post-t change | −2.54 | [−3.01, − 2.07] | .000* | – |
19 week change | −2.98 | [− 3.51, − 2.45] | .000* | – |
Control | 0.00 | 419 | ||
myCompass | 0.22 | [−0.36, − 0.80] | .449 | 383 |
Active users | 0.65 | [−0.71, −2.01] | .350 | 35 |
GAD-7 | ||||
Pre-treatment | 9.05 | [8.73, 9.37] | – | – |
Post-t change | −2.04 | [−2.45, −1.62] | .000* | – |
19 week change | −2.10 | [−2.56, − 1.63] | .000* | – |
Control | 0.00 | – | – | 419 |
myCompass | 0.24 | [−0.21, 0.69] | .300 | 383 |
Active users | 0.26 | [−0.78, 1.30] | .625 | 35 |